Previous Chapter: 1 Introduction
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 10
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 11
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 12
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 13
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 14
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 15
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 16
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 17
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 18
Suggested Citation: "2 Regulatory Framework." Institute of Medicine. 2008. Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/11911.
Page 19
Next Chapter: 3 Current Challenges in Developing and Prescribing Drugs for Children
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.